Re-Examining The GLP-1 Drug Boundaries (Part 1). Legal News and Analysis - India - Regulatory & Compliance - Conventus Law ...
Ganapathy Viswanathan, Independent Communication Consultant & Author, writes about the need for the IPL to enforce surrogate ...
March 11 (Reuters) - India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could act ...
NEW DELHI: The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for prescription-only drugs. The regulator in an ...
Battling concerns that a third of the Indian population will become obese by 2050, the Central Drugs Standard Organisation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results